Which Best Investors: Healthcare Stability vs Biotech Growth
Choosing between broad healthcare stability and biotech growth can shape your portfolio. Learn how XLV and IBBQ diffe...
Discover the importance of using asset allocation to balance risk and return. This strategy can enhance your investment performance.
28,655 articlesChoosing between broad healthcare stability and biotech growth can shape your portfolio. Learn how XLV and IBBQ diffe...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Nike has faced a decades-long love-hate relationship with investors: the brand remains powerful, but the stock has sl...
Freddie Mac data show mortgage rates jump highest in nearly a year, with the 30-year fixed at about 6.55% as buyers w...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
A convincing fake bank call sent a Virginia resident on a cash handoff, revealing how scammers use authority and urge...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...